Intelligence · Patents
Patents expiring in 2027
Annual patent cliff calendar for 2027 — US pharmaceutical patents by expiration date.
- Patents
- 578
Quick answer
578 indexed pharmaceutical patents have expiration dates in 2027. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7220739
Therapeutic application of pro-apoptotic benzodiazepines
granted -
US 7223406
Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
granted -
US 7223836
Peptides for chlamydophila pneumoniae vaccine and diagnosis
granted -
US 7223787
Prenylation inhibitors reduce host cell permissiveness to viral replication
granted -
US 7223388
Modified reoviral therapy
granted -
US 7223726
Apolipoprotein A-I mutant proteins having cysteine substitutions and polynucleotides encoding same
granted -
US 7223783
Indolinone derivatives
granted -
US 7223563
Fibroblast growth factor (FGF23) nucleic acids
granted -
US 7223424
Compositions and methods for prostate and kidney health and disorders, an herbal preparation
granted -
US 7223585
Viral purification methods
granted -
US 7223571
Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
granted -
US 7223791
Function regulator for retinoid relative receptor
granted -
US 7223844
Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by Env-CD4-co-receptor complexes
granted -
US 7223853
Secreted frizzled related protein fragments
granted -
US 7223803
Polyethylene (glycol) derivatives with proximal reactive groups
granted -
US 7223380
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
granted -
US 7226602
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
granted -
US 7226589
Treatment of diseases by site specific instillation of cells or site specific transformation of cells and kits therefor
granted -
US 7226991
Phenylalanine derivatives
granted -
US 7226588
Non-toxic mutants of pathogenic gram-negative bacteria
granted -
US 7226609
Sodium dodecyl sulfate compositions for inactivating prions
granted -
US 7226597
Mutants of Clostridium difficile toxin B and methods of use
granted -
US 7226920
Aminotriazole compounds useful as inhibitors of protein kinases
granted -
US 7226937
Methods for modulating phototoxicity
granted -
US 7226950
Sodium channel modulators
granted -
US 7227010
Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy
granted -
US 7227009
MT-SP1 polynucleotides and polypeptides
granted -
US 7227011
Nucleic acid vaccines for prevention of flavivirus infection
granted -
US 7226946
Substituted phenol compounds useful for anesthesia and sedation
granted -
US 7229628
Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
granted -
US 7229972
3,6-Bicyclolides
granted -
US 7229604
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
granted -
US 7229641
Rapid-melt compositions methods of making same and methods of using same
granted -
US 7229770
YKL-40 as a marker and prognostic indicator for cancers
granted -
US 7229826
Process for ex vivo formation of mammalian bone and uses thereof
granted -
US 7229949
Safe delivery system for agriculturally active material
granted -
US 7230086
Assay for YKL-40 as a marker for degradation of mammalian connective tissue matrices
granted -
US 7229995
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
granted -
US 7230004
Cyclopamine analogues and methods of use thereof
granted -
US 7229986
Melanin-concentrating hormone antagonist
granted -
US 7229627
Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production
granted -
US 7229963
Methods of using deacetylase inhibitors to promote cell differentiation and regeneration
granted -
US 7232684
DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use
granted -
US 7232887
Melanoma antigens and their use in diagnostic and therapeutic methods
granted -
US 7232671
Pertussis toxin gene: cloning and expression of protective antigen
granted -
US 7232566
Methods for treating HIV infected subjects
granted -
US 7232570
ERAAP modulators regulate immune responses
granted -
US 7232890
AIB1, a novel steroid receptor co-activator
granted
Frequently asked questions
How many pharma patents expire in 2027?
578 published patents in our USPTO index have expiration dates falling in calendar year 2027.